Sijmen de Vries
Fortuna: - $ al 31/07/2026
Fortuna: - $ al 31/07/2026
Sijmen de Vries is currently Chief Executive Officer at Pharming Intellectual Property BV, Non-Executive Director at Sylus Pharmaceuticals Ltd. since 2010, Independent Non-Executive Director at Biodexa Pharmaceuticals Plc since 2014, and Finish Partner at BioConnection BV.
Former roles include Chief Executive Officer at Morphochem AG and 4-Antibody AG, Executive Director at Pharming Group NV from 2008 to 2025, and Non-Executive Director at Biodexa Ltd. from 2004 to 2015.
Education includes a doctorate from the University of Amsterdam and an MBA from Ashridge Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Director/Miembro de la Junta | 13/11/2014 |
Sylus Pharmaceuticals Ltd. | Director/Miembro de la Junta | 21/06/2010 |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Director Ejecutivo | - |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| PHARMING GROUP N.V. | Director Ejecutivo | 04/03/2025 |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Director/Miembro de la Junta | 13/03/2015 |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Director Ejecutivo | - |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Commercial Services |
University of Amsterdam
University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Ashridge Business School
Ashridge Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Health Technology |
Sylus Pharmaceuticals Ltd. | |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Producer Manufacturing |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.